(October 11, 2018, 1:01 PM EDT) -- WASHINGTON, D.C. — A federal judicial panel on Oct. 10 denied a motion to centralize 26 federal linear gadolinium-based contrast agent lawsuits in a multidistrict litigation, saying the common questions of fact and law are not “sufficiently complex or numerous” to justify centralization (In Re: Linear Gadolinium-Based Contrast Agents Products Liability Litigation, MDL Docket No. 2868, JPMDL)....